In today’s digital marketplace, pharmaceutical brand protection is more critical than ever. Counterfeit pharmaceuticals continue to infiltrate online platforms, posing dangerous risks to consumers and
As 2025 winds down, pharmaceutical and controlled substance manufacturers are facing a shifting compliance landscape. Now is the ideal time to prepare for DEA regulatory
Navigating DEA compliance within large hospital systems is far more complex than most administrators realize. Unlike retail pharmacies, hospital pharmacies must coordinate across multiple departments, campuses, and treatment sites—all
As the pharmaceutical industry heads into Q4, compliance leaders are keeping a close eye on emerging regulatory priorities. October 2025 is proving to be a
Suspicious Order Monitoring (SOM) is a vital compliance requirement under the Code of Federal Regulations (CFR) for DEA-registered wholesale drug distributors. At its core, SOM
Running a pharmacy involves more than filling prescriptions—it requires rigorous pharmacy compliance to meet federal and state regulations. Whether you operate a community pharmacy or a large
Counterfeit pharmaceuticals sold online have become a dangerous global issue. Not only do fake medicines put consumers’ health at serious risk, but they also damage
Pharmacists are on the front lines of public health—and when it comes to controlled substances, their decisions carry serious legal weight. Under the Controlled Substances
